DR. SANDRA HOLLANDER, MD, FACP
She is experienced at the diagnosis and treatment of the full range of cancers and blood disorders. Dr Sandra Hollander female side allows her that special compassion when dealing with women’s and men’s cancer issues. Her compassion in treating the whole patient emphasizes the quality of life.
Dr Sandra Hollander was named in the Consumers’ Research Council of America’s – Guide to Americas Top Physicians and New Jersey Monthly Magazine’s – Top Doctors.
Find out why many of her former patients say “Thank God for Dr Sandra Hollander.”
PRIOR ACADEMIC RANK AND POSITION
Voluntary Teaching Staff
Department of Medicine
AtlanticCare Regional Medical Center (formerly Atlantic City Medical Center), Atlantic City
Dr Sandra Hollander graduated from the State University of New York at Syracuse, College of Environmental Science and Forestry in 1977 obtaining a Bachelor of Science degree with a Grade Point Average of 3.7.
She continued to Graduate School at the State University of New York at Buffalo, Roswell Park Memorial Institute obtaining her Master’s Degree in Experimental Pathology – September 1, 1979 with a Grade Point Average of 3.7.
Dr Sandra Hollander research, thesis and Master’s degree (taken in the Medical Campus) were accepted as her first two years of Medical School. She entered Ross University School of Medicine as a third year student and performed all her Clinical Rotations in US. She obtained her MD Degree in 1981.
Her Internship and Residency was at the prestigious St. Barnabas Medical Center in Livingston, NJ, completed in 1984.
Dr Sandra Hollander found her niche in Medicine was in Hematology and Oncology and entered a combined fellowship at the prestigious State University of New York at Stony Brook, University Hospital and VA Medical Center at Northport, New York. She completed this dual fellowship in 1987.
American Board of Internal Medicine
Oncology Sub specialty Board Certification – November, 1987
Hematology Sub specialty Board Certification – November, 1986
Internal Medicine – September, 1984
HONORS AND AWARDS
Graduated Magna Cum Laude
Member of Phi Kappa Phi Honor Society
Member of Alpha Xi Sigma Honor Society
Graduated Magna Cum Laude
Post Graduate: A Fellow in the American College of Physicians (FACP) – Jan. 1, 1997 PROFESSIONAL POSITIONS
Reliance Medical Group, Galloway, NJ 2012- 2013 Atlantic Hematology Oncology Group, Galloway, New Jersey, 1990 –2012. For many years Dr. Hollander was the leader of this “Patientcentric” practice that focused on the patient.
Former clinician at the AtlantiCare Cancer Care Institute (formerly RNS Regional Cancer Center at the Atlantic City Medical Center). Clinical Assistant Professor of Medicine Division of Hematology / Oncology University of Medicine and Dentistry of New Jersey Stratford, New Jersey 1988 -1990
Co-coordinator of Ambulatory Care Sickle Cell Program, Camden, New Jersey, 1989 – 1990
EDUCATION – TEACHING
Introduction to Clinical Medicine
State University of New York at Stony Brook
Northport VA Medical Center
Internal Medicine Residents, University of Medicine and Dentistry, Stratford, NJ, 1988 – 1990
Voluntary Teaching Staff, Atlantic City Medical Center, Residency Program
Division of Hematology and Oncology, AtlanticCare Regional Medical Center (formerly Atlantic City Medical Center), Atlantic City and Pomona, NJ, 1995 – 1998
Clinical Research Committee
PROFESSIONAL AND SOCIETY MEMBERSHIPS
American Medical Association
American College of Physicians (Past)
American Society of Clinical Oncology
MASTER’S THESIS – “A STUDY OF PLATELET AGGREGATION INHIBITORS ON NEPHROBLASTOMA IN WISTAR-FURTH STRAIN RATS,” S. L. Gordon; Buffalo, New York, 1979.
“STUDIES ON PLATELET AGGREGATION INHIBITORS IN VIVO VIII. EFFECT OF PENTOXIFYLLINE ON SPONTANEOUS TUMOR METASTASIS,” S. Gordon, J. L. Ambrus, MD, et. al., J. of Med., Vol.10, No.6, 1979, P.435- 443.
“IDENTIFICATION OF TISSUE FACTOR IN TWO HUMAN PANCREATIC CANCER CELL LINES,” J. M. Silberberg, MD, S. Gordon, MD, S. Zucker, MD, Clinical Research (Abstract) Vol. 34; No.3 Sept. 1986, P.882A.
“HEMOLYTIC UREMIC SYNDROME IN A PATIENT WITH SMALL CELL LUNG CANCER,” L. Avvento, MD, S. Gordon, MD, J. M. Silberberg, MD, M. H. Zarrabi, MD, FACP, S. Zucker, MD, FACP, Am. J. Hematol., 1988:Mar;27 (3):221-3.
“AN UNUSUAL CASE OF CHRONIC LYMPHOCYTIC LEUKEMIA,” S. L. Hollander, J. of Med. Vol. 22 Nos. 4&5, P.289-297, 1991.
“REVIEW OF PLATINUM ANTICANCER COMPOUNDS,” M. Gordon and S. L. Hollander, J. of Med.: Vol.24, Nos. 4&5, P.209-265, 1993.
“THE ROLE OF PRIMARY CARE IN CANCER SCREENING AND PREVENTION,” Findings, Vol.2 No.1 P. 18-19, 1993, S. L. Hollander.
“RETROSPECTIVE ANALYSIS OF FIVE YEAR EXPERIENCE WITH CARCINOMA OF THE ESOPHAGUS,” Middleman, E. L., Hollander, S. L., Meltzer, J. I., Nazha, N. T. and Cassir, J. F. (Abstract)
“RECOMBINANT ERYTHROPOIETIN IN -THALASSEMIA INTERMEDIA: A CASE STUDY”, Findings, Vol.9, p.76-78, 2000, S. L. Hollander.
“HODGKIN’S DISEASE OF THE NASOPHARYNX,” S. L. Hollander, JCO, Vol. 22, No. 1, Jan. 1, 2004, p. 195 – 196.
“THE PLATEAU IN CYTOTOXIC CANCER DRUG DISCOVERY – AN UPDATE SIXTEEN YEARS LATER, INCLUDING EMERGENT TARGETING OF CANCER DRUGS,” Sandra Hollander, MD, FACP and Maxwell Gordon, PhD, J. of Med. Vol. 36 (1-6), p. 147-167.
Dr. Sandra Hollander, M.D., F.A.C.P. is triple board certified in Internal Medicine, Hematology and Oncology. She earned her Master’s Degree in Experimental Pathology and was motivated into the field of Oncology by her father, Dr. Maxwell Gordon who was the developer of one of the breakthrough cancer drugs, cis – Platinum.
Dr Sandra Hollander has an extensive background having practiced as an Assistant Professor of Hematology and Oncology at the University of Medicine and Dentistry of New Jersey and Atlantic Hematology Oncology Group, a community based practice in Galloway, NJ for over 20 years. She served as Director of the Division of Hematology and Oncology at AtlantiCare Regional Medical Center.